Orlevol en es it fr

Orlevol Brand names, Orlevol Analogs

Orlevol Brand Names Mixture

  • No information avaliable

Orlevol Chemical_Formula


Orlevol RX_link

No information avaliable

Orlevol fda sheet

Orlevol msds (material safety sheet)

Orlevol Synthesis Reference

No information avaliable

Orlevol Molecular Weight

309.469 g/mol

Orlevol Melting Point

< 25 oC

Orlevol H2O Solubility

Soluble as HCl salt

Orlevol State


Orlevol LogP


Orlevol Dosage Forms

Tablets (oral, 1 mg)

Orlevol Indication

Used for the symptomatic treatment of parkinsonism.

Orlevol Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Orlevol Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Orlevol side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Orlevol Patient Information

Orlevol Organisms Affected

Humans and other mammals